Mass spectrometry-based metabolomics in recurrent ischemic stroke: pathophysiological insights, treatment resistance, and synergistic therapies.

Liu S, Fong SY, Liu H, Sun P

Open source

DOI
10.1186/s40001-025-03710-0
Published
2025 Dec 30
Container
European journal of medical research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s40001-025-03710-0,
  title = {Mass spectrometry-based metabolomics in recurrent ischemic stroke: pathophysiological insights, treatment resistance, and synergistic therapies.},
  author = {Liu S and Fong SY and Liu H and Sun P},
  year = {2025},
  journal = {European journal of medical research},
  doi = {10.1186/s40001-025-03710-0},
  url = {https://doi.org/10.1186/s40001-025-03710-0}
}

RIS

TY  - JOUR
TI  - Mass spectrometry-based metabolomics in recurrent ischemic stroke: pathophysiological insights, treatment resistance, and synergistic therapies.
AU  - Liu S
AU  - Fong SY
AU  - Liu H
AU  - Sun P
PY  - 2025
JO  - European journal of medical research
DO  - 10.1186/s40001-025-03710-0
UR  - https://doi.org/10.1186/s40001-025-03710-0
ER  - 

APA

S, L., SY, F., H, L., & P, S. (2025). Mass spectrometry-based metabolomics in recurrent ischemic stroke: pathophysiological insights, treatment resistance, and synergistic therapies.. European journal of medical research. https://doi.org/10.1186/s40001-025-03710-0

Source records